Dear Colleague,

The Nanobiotechnology in Drug Discovery conference will take place on December 4-6 at the Pennsylvania Convention Center in Philadelphia, PA as a part of GTCbio's 2nd Modern Drug Discovery and Development Summit (M3D). Nanobiotechnology in Drug Discovery will focus on three areas in which nanotechnology is on the cutting edge of drug discovery and development: nanobiotechnology and cancer, drug discovery and tools, nanobiotechnology and medicine, and more.

Abstracts Deadline: Extended to October 27, 2006.
Register by Oct 27 to receive 10% discount.

Nanobiotechnology Presenters:
Stephen Barry, Alnis BioSciences
Eric Henderson, BioForce Nanosciences
Tanya Kanigan, Biotrove
Milan Stojanovic, Columbia School of Medicine
Amit Kumar, Combimatrix
Giulio F. Paciotti, CytImmune Sciences, Inc.
Donald Tomalia, Dendritic Nanotechnologies
Yaakov Benenson, Harvard University
Ali Khademhosseini, Harvard Medical School
Patrick Y. Lu, Intradigm Corporation
Fanqing Frank Chen, Lawrence Berkeley National laboratory
Jason Kang, Macrogen
William Moffitt, Nanosphere
Lawrence Bock, Nanosys Inc.
Scott McNeil, Nanotech Characterization Lab, NCI
Robert Lee, NCI OSU Comprehensive Cancer Center
Jacek Capala, NIH
Remy Cromer, Oxonica, Inc.
Peixuan Guo, Purdue Bionanotech Interdisciplinary Graduate Program
Paul Schaudies, SAIC
Guy Krippner, Starpharma
Viola Vogel, Swiss Federal Institute of Technology, ETH
Giovanni Zocchi, UCLA
Scott Diamond, University of Pennsylvania
Chris Geddes, University of Maryland Biotechnology Institute
Daniel A. Hammer, University of Pennsylvania


Upcoming Events

3rd Tumor Progression and Therapeutic Resistance
Oct. 22-24, 2006
Baltimore, MD

Immunodiagnostics & Immunomonitoring: From Research to Clinic
Nov. 5-7, 2006
Washington, DC

4th Vaccines:
All Things Considered
Nov. 16-17, 2006 Washington, DC
 Register by Sept. 16 to receive 20% discount

2nd Modern Drug Discovery and Development
Dec. 4-6, 2006
Philadelphia, PA
11 Full Conferences:

      1. Systems Biology
      2. Model Organisms
      3. CNS Diseases
      4. Nanobiotechnology
      5. Antibody Discovery
      6. Drug Delivery Tech.
      7. Medicinal Chemistry
      8. Epigenetics
      9. Stem Cell Research
      10. Drug Safety
      11. Partner & License

                      

4th Anti-Infectives Partnering & Deal-Making Summit
Jan. 25-26, 2007
San Francisco, CA

5th Cytokines & Inflammation
Jan. 29-30, 2007
Breckenridge, CO

a
The Nanobiotechnology in Drug Discovery conference is one of 11 concurrent conferences taking place during M3D 2006. Over 275 speakers will participate in the following 11 conferences:

1.   Systems Biology in Drug Discovery
2.   Model Organisms in Drug Discovery
3.   CNS Diseases and Drug Discovery
4.   Nanobiotechnology in Drug Discovery
5.   Antibody Discovery and Development
6.   Drug Delivery Technology
7.   Medicinal Chemistry
8.   Epigenetic Cancer Therapy
9.   Stem Cell Research and Regenerative Medicine
10. Drug Safety and Pharmacovigilance
11. Biotech and Pharmaceutical Licensing and Deal-Making

Visit www.gtcbio.com for discounts and more information. Register 2 and the 3rd goes free!
 a
Plenary Keynote Speakers:

Mahdi Fawzi, PhD  Executive VP,
Pre-Clinical Development, Wyeth Research

Lester Crawford, PhD Former FDA Commissioner, Sr. Counsel,
Policy Directions

Allen D. Roses, MD Senior Vice President, Pharmacogenetics GlaxoSmithKline

Keith James
SVP, Strategic Management Group,
Pfizer, Inc.

James Summers, PhD  VP, Advanced Technology,
Global Pharma Disc. Abbott Labs

Call 626-256-6405 or email sales@gtcbio.com for Sponsor and Exhibit Information
This advertisement comes to you from GTCbio, 434 W. Foothill Blvd, Monrovia, CA 91016. To update your contact information, please click here. If you prefer not to receive further messages from this sender, <HTMLRemoval> your name from the mailing list. If your browser doesn't allow you to use the removal link, please copy and paste the following into your browser and hit enter. <RemovalURL>